TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005
